North American cost analysis of brand name versus generic drugs for the treatment of glaucoma.

Published in: ClinicoEconomics and outcomes research : CEOR (2019)

Brand-name drugs are relatively more expensive than their generic counterparts, with variable cost differentials depending on drug class.

Keyphrases